Page last updated: 2024-08-23

bm 13505 and Injury, Myocardial Reperfusion

bm 13505 has been researched along with Injury, Myocardial Reperfusion in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19904 (66.67)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Auchampach, JA; Ge, ZD; Gross, GJ; Piper, GM1
Lefer, AM; Ma, XL; Viehman, GE1
DiMartino, MJ; Egan, JW; Griswold, DE; Hillegass, LM; Smith, EF1
Lefer, AM1
Earl, CQ; Egan, JW; Griswold, DE; Hillegass, LM; Marshall, PJ; Smith, EF1
Bhat, AM; Lefer, AM; Osborne, JA; Sacks, H1

Other Studies

6 other study(ies) available for bm 13505 and Injury, Myocardial Reperfusion

ArticleYear
Comparison of cardioprotective efficacy of two thromboxane A2 receptor antagonists.
    Journal of cardiovascular pharmacology, 2003, Volume: 41, Issue:3

    Topics: Animals; Benzenesulfonates; Cardiotonic Agents; Cycloheptanes; Dogs; Myocardial Reperfusion Injury; Phenylacetates; Receptors, Thromboxane; Sulfonamides

2003
Daltroban, a thromboxane receptor antagonist, protects the myocardium against reperfusion injury following myocardial ischemia without protecting the coronary endothelium.
    Methods and findings in experimental and clinical pharmacology, 1990, Volume: 12, Issue:10

    Topics: Animals; Cats; Coronary Vessels; Endothelium, Vascular; Male; Myocardial Reperfusion Injury; Myocardium; Necrosis; Peroxidase; Phenylacetates; Sulfonamides; Thromboxanes; Vasoconstriction

1990
Reduction of myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion by the thromboxane receptor antagonist BM 13.505.
    Journal of cardiovascular pharmacology, 1989, Volume: 13, Issue:5

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cardiomyopathies; Creatine Kinase; Hemodynamics; Male; Myocardial Reperfusion Injury; Myocardium; Neutrophils; Peroxidase; Phenylacetates; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Sulfonamides; Thromboxanes

1989
Role of thromboxane A2 in myocardial ischemia and circulatory shock.
    Advances in prostaglandin, thromboxane, and leukotriene research, 1989, Volume: 19

    Topics: Animals; Cats; Coronary Disease; Myocardial Reperfusion Injury; Phenylacetates; Platelet Aggregation; Rabbits; Shock; Sulfonamides; Thromboxane A2; Thromboxanes

1989
Reduction of myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion by the thromboxane receptor antagonist BM 13.505.
    Progress in clinical and biological research, 1989, Volume: 301

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Coronary Disease; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Neutrophils; Phenylacetates; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides

1989
Protective effect of the specific thromboxane receptor antagonist, BM-13505, in reperfusion injury following acute myocardial ischemia in cats.
    American heart journal, 1989, Volume: 117, Issue:4

    Topics: Acute Disease; Animals; Blood Pressure; Cats; Coronary Disease; Creatine Kinase; Electrocardiography; Heart Rate; Male; Myocardial Reperfusion Injury; Myocardium; Necrosis; Phenylacetates; Sulfonamides; Thromboxanes

1989